Ultragenyx Pharmaceutical (RARE) Dividends Paid - Common (2014)

Ultragenyx Pharmaceutical (RARE) reported Dividends Paid - Common of $4.3 million for Q1 2014.

Ultragenyx Pharmaceutical (RARE) Dividends Paid - Common (2014) Analysis & Trends

Ultragenyx Pharmaceutical (RARE) has 1 years of Dividends Paid - Common data on file, last reported at $4.3 million in Q1 2014.

Dividends Paid - Common for Q1 2014 came in at $4.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2014 was $4.3 million (changed N/A YoY), and the FY2014 annual result was $4.3 million, changed N/A from the prior year.
Dividends Paid - Common was little changed at $4.3 million in Q1 2014 per RARE's latest filing.
Over five years, Dividends Paid - Common peaked at $4.3 million in Q1 2014 and troughed at $4.3 million in Q1 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Dividends Paid - Common (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Ultragenyx Pharmaceutical	2.77 Bn	2.36 Bn	106.00 Mn	-

Download Data

Date	Value
Mar 31, 2014	4.35 Mn
Mar 31, 2014	4.35 Mn